Skip to main content
. Author manuscript; available in PMC: 2015 Jun 15.
Published in final edited form as: Clin Cancer Res. 2014 Apr 11;20(12):3319–3327. doi: 10.1158/1078-0432.CCR-14-0069

Table 1.

Patient demographics by KRAS-LCS6 status

Carrier
(N=432)
wild-type
(N=2402)
Total
(N=2834)
p value
Age, years 0.391
    N 432 (15.2) 2402 (84.8) 2834 (100.0)
    Median 58.00 58.00 58.00
    Range (22.00–85.00) (19.00–86.00) (19.00–86.00)
Age, n (%) 0.182
    <50 89 (13.6) 566 (86.4) 655 (23.1)
    >=50 343 (15.7) 1836 (84.3) 2179 (76.9)
Sex, n (%) 0.912
    Female 201 (15.2) 1125 (84.8) 1326 (46.8)
    Male 231 (15.3) 1277 (84.7) 1508 (53.2)
Race, n (%) <0.00012
    Caucasian 419 (17.2) 2021 (82.8) 2440 (87.5)
    Black or African-American 6 (3.1) 190 (96.9) 196 (7.0)
    Asian 1 (0.8) 131 (99.2) 132 (4.7)
    Other 0 (0.0) 22 (100.0) 22 (0.8)
    Missing 6 38 44
Treatment Arms, n (%) 0.782
  FOLFOX 177 (15.1) 997 (84.9) 1174 (41.4)
  FOLFIRI 15 (17.2) 72 (82.8) 87 (3.1)
  FOLFOX × 6 → FOLFIRI × 6 12 (12.4) 85 (87.6) 97 (3.4)
  FOLFOX + C225 168 (14.9) 956 (85.1) 1124 (39.7)
  FOLFIRI+ C225 3 (10.0) 27 (90.0) 30 (1.1)
  FOLFOX × 6 → FOLFIRI × 6 + C225 6 (19.4) 25 (80.6) 31 (1.1)
  Treatment per local physician discretion 51 (17.5) 240 (82.5) 291 (10.3)
1

Unequal Variance Two Sample T-Test

2

Chi-Squared Test